Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 844.270
- -26.090-3.00%
Close Feb 14 16:00 ET
- 844.000
- -0.270-0.03%
Post 20:01 ET
801.48BMarket Cap72.10P/E (TTM)
873.500High841.490Low3.22MVolume869.100Open870.360Pre Close2.75BTurnover0.34%Turnover Ratio72.10P/E (Static)949.32MShares969.23352wk High56.28P/B799.76BFloat Cap710.16952wk Low5.20Dividend TTM947.29MShs Float969.233Historical High0.62%Div YieldTTM3.68%Amplitude5.269Historical Low853.628Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Jon R. Moeller
- Independent Director
- --
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
- Jamere Jackson
- Independent Director
- 345.00K
- Jon Erik Fyrwald
- Independent Director
- 344.88K
- Katherine Baicker
- Independent Director
- 336.00K
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Ralph Alvarez
- Independent Director
- 336.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
